Market revenue in 2023 | USD 1,342.1 million |
Market revenue in 2030 | USD 2,210.7 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the France formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
France is among the top 8 pharmaceutical markets worldwide in terms of revenue size. Pharmaceutical companies have been rapidly growing in the country over the last few decades. The country remains a highly regulated market with a lower rate of generic drug penetration.
This factor indirectly emphasizes the need for innovative drugs, facilitating the country's clinical trials and R&D projects. The supportive government initiatives—such as Choose France event that showcases the country’s economic appeal & encourages foreign investments in the country—are anticipated to boost the drug formulation and commercialization activities in the country.
Most companies outsource drug formulation processes to third parties due to the complexity of the process, high operation costs & requirements of advanced infrastructure, and lack of workforce. These factors support the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the France formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into France formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account